RETA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $41,292,884.28

Reata Pharmaceuticals Insider Trading History Chart

Reata Pharmaceuticals Share Price & Price History

^$172.36

+0.30 (1.20%)

As of 09/26/2023 01:00 AM ET

Days: 30 | 90 | 365

Unlock the treasure on Mount Olympus with this little-known mining stock.

From Micro-Cap Stock Trader | Ad

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

Download Free Report

Reata Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/14/2023	Andrea Loewen	SVP	Sell	3,175	$172.03	$546,195.25	28,416
7/28/2023	Dawn Carter Bir	Insider	Sell	40,000	$164.54	$6,581,600.00	35,010
7/28/2023	Manmeet Singh Soni	CFO	Sell	75,000	$164.62	$12,346,500.00	64,376
7/28/2023	Shamim Ruff	Director	Sell	8,235	$164.53	$1,354,904.55	7,359
6/14/2023	Bhaskar Anand	CAO	Sell	2,343	$102.11	$239,243.73	24,898
6/13/2023	Manmeet Singh Soni	CFO	Sell	78,085	$102.89	$8,034,165.65	58,376
5/15/2023	Andrea Loewen	SVP	Sell	103	$84.71	$8,725.13	31,904
5/15/2023	Manmeet Singh Soni	CFO	Sell	21,507	$84.56	$1,818,631.92	116,797
5/15/2023	Michael D. Wortley	Insider	Sell	894	$84.81	$75,820.14	47,198
5/12/2023	Andrea Loewen	SVP	Sell	6,750	$86.26	$582,255.00	32,007
3/10/2023	Shamim Ruff	Director	Sell	5,740	$83.73	$480,610.20	5,223
3/7/2023	Andrea Loewen	SVP	Sell	19,036	$83.43	$1,588,173.48	38,757
3/7/2023	Bhaskar Anand	CAO	Sell	165	$84.58	$13,955.70	26,765
3/6/2023	Dawn Carter Bir	Insider	Sell	54,954	$89.56	$4,921,680.24	41,925
3/3/2023	Bhaskar Anand	CAO	Sell	820	$87.47	$71,725.40	26,930
3/3/2023	Dawn Carter Bir	Insider	Sell	2,166	$88.25	$191,149.50	48,509
3/3/2023	Manmeet Singh Soni	CFO	Sell	3,587	$87.97	$315,548.39	88,926
3/2/2023	Samina Khan	SVP	Sell	25,000	$84.88	$2,122,000.00	46,905
6/14/2021	Colin John Meyer	Insider	Sell	20,000	$144.05	$2,881,000.00	77,000
6/9/2021	Elaine Castellanos	CAO	Sell	8,454	$141.90	$1,199,622.60	16,092
6/7/2021	Elaine Castellanos	CAO	Sell	1,546	$146.75	$226,875.50	16,092
5/26/2021	Elaine Castellanos	CAO	Sell	10,000	$124.55	$1,245,500.00	24,546
11/11/2020	Michael D. Wortley	Insider	Sell	51,429	$179.37	$9,224,819.73	51,429
11/10/2020	James Warren Huff	CEO	Sell	81,657	$175.01	$14,290,791.57

Unlock the treasure on Mount Olympus with this little-known mining stock.

From Micro-Cap Stock Trader | Ad

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

Download Free Report

SEC Filings (Institutional Ownership Changes) for Reata Pharmaceuticals (NASDAQ:RETA)

Institutional Buying and Selling by Quarter

Reata Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	79,034	$8.06M	0.0%	+371.7%	0.207%
8/24/2023	Perceptive Advisors LLC	670,206	$68.33M	2.0%	-69.1%	1.757%
8/21/2023	VisionPoint Advisory Group LLC	403	$41K	0.0%	N/A	0.001%
8/21/2023	Affinity Asset Advisors LLC	29,105	$2.97M	1.0%	N/A	0.076%
8/21/2023	California State Teachers Retirement System	30,693	$3.13M	0.0%	-9.7%	0.080%
8/21/2023	Osaic Holdings Inc.	5,406	$0.55M	0.0%	-34.6%	0.014%
8/16/2023	GTS Securities LLC	7,833	$0.80M	0.0%	N/A	0.021%
8/15/2023	Alliancebernstein L.P.	131,235	$13.38M	0.0%	+90.3%	0.349%
8/15/2023	Wells Fargo & Company MN	12,783	$1.30M	0.0%	+84.8%	0.034%
8/15/2023	Blueshift Asset Management LLC	4,007	$0.41M	0.2%	N/A	0.011%
8/15/2023	Integrated Wealth Concepts LLC	11,171	$1.14M	0.0%	-1.1%	0.030%
8/15/2023	Woodline Partners LP	205,108	$20.91M	0.2%	N/A	0.546%
8/15/2023	Goldman Sachs Group Inc.	218,143	$22.24M	0.0%	+52.8%	0.581%
8/15/2023	Captrust Financial Advisors	12,545	$1.28M	0.0%	N/A	0.033%
8/15/2023	Point72 Asset Management L.P.	568,151	$57.93M	0.2%	+56.0%	1.513%
8/15/2023	Polar Asset Management Partners Inc.	83,400	$8.50M	0.2%	N/A	0.222%
8/15/2023	Royal Bank of Canada	3,462	$0.35M	0.0%	+77.4%	0.009%
8/15/2023	Rockefeller Capital Management L.P.	6,534	$0.67M	0.0%	+0.9%	0.017%
8/15/2023	Silverarc Capital Management LLC	12,500	$1.27M	0.4%	N/A	0.033%
8/15/2023	Stifel Financial Corp	14,983	$1.53M	0.0%	+0.8%	0.040%
8/15/2023	Suvretta Capital Management LLC	108,832	$11.10M	0.6%	+620.7%	0.290%
8/15/2023	Holocene Advisors LP	667,950	$68.10M	0.3%	+119.2%	1.779%
8/15/2023	Hudson Bay Capital Management LP	40,000	$4.08M	0.0%	N/A	0.107%
8/15/2023	Boxer Capital LLC	1,430,004	$145.80M	6.8%	+16.3%	3.808%
8/14/2023	PDT Partners LLC	4,806	$0.49M	0.1%	-88.9%	0.013%
8/14/2023	NinePointTwo Capital LLC	2,868	$0.29M	0.1%	N/A	0.008%
8/14/2023	Tolleson Wealth Management Inc.	33,250	$3.39M	0.8%	-17.4%	0.089%
8/14/2023	Tower Research Capital LLC TRC	1,633	$0.17M	0.0%	+114.9%	0.004%
8/14/2023	Schonfeld Strategic Advisors LLC	114,520	$11.68M	0.1%	+108.4%	0.305%
8/14/2023	Marshall Wace LLP	84,508	$8.62M	0.0%	-79.6%	0.225%
8/14/2023	State of Wisconsin Investment Board	27,437	$2.80M	0.0%	+13.2%	0.073%
8/14/2023	State Street Corp	713,150	$72.71M	0.0%	+12.7%	1.899%
8/14/2023	UniSuper Management Pty Ltd	29,324	$2.99M	0.0%	N/A	0.078%
8/14/2023	Nuveen Asset Management LLC	94,039	$9.59M	0.0%	-15.4%	0.250%
8/14/2023	Driehaus Capital Management LLC	94,945	$9.68M	0.1%	N/A	0.253%
8/14/2023	Prelude Capital Management LLC	10,550	$1.08M	0.1%	N/A	0.028%
8/14/2023	Wallace Capital Management Inc.	22,175	$2.26M	0.3%	N/A	0.059%
8/11/2023	Nan Fung Group Holdings Ltd	3,300	$0.34M	0.2%	N/A	0.009%
8/11/2023	Credit Suisse AG	42,577	$4.34M	0.0%	+2.7%	0.113%
8/11/2023	BlackRock Inc.	2,538,770	$258.85M	0.0%	+14.9%	6.761%
8/11/2023	Ameritas Investment Partners Inc.	2,360	$0.24M	0.0%	+9.6%	0.006%
8/11/2023	Harvest Investment Services LLC	18,655	$1.90M	1.1%	+81.2%	0.050%
8/11/2023	Biondo Investment Advisors LLC	12,750	$1.30M	0.2%	+259.2%	0.034%
8/11/2023	Sectoral Asset Management Inc.	47,500	$4.84M	0.8%	+90.0%	0.126%
8/11/2023	State Board of Administration of Florida Retirement System	8,117	$0.83M	0.0%	-6.8%	0.022%
8/11/2023	The Manufacturers Life Insurance Company	16,068	$1.64M	0.0%	-21.3%	0.043%
8/11/2023	Franklin Resources Inc.	14,166	$1.44M	0.0%	+387.3%	0.038%
8/11/2023	Atika Capital Management LLC	22,000	$2.24M	0.2%	N/A	0.059%
8/11/2023	Geode Capital Management LLC	593,430	$60.51M	0.0%	+8.0%	1.580%
8/11/2023	Sei Investments Co.	41,890	$4.27M	0.0%	+238.9%	0.112%
8/11/2023	JPMorgan Chase & Co.	206,223	$21.03M	0.0%	-52.4%	0.549%
8/11/2023	PNC Financial Services Group Inc.	4,156	$0.42M	0.0%	+1.5%	0.011%
8/11/2023	Northern Trust Corp	287,968	$29.36M	0.0%	+1.8%	0.767%
8/10/2023	MetLife Investment Management LLC	15,065	$1.54M	0.0%	+4.3%	0.040%
8/10/2023	Osaic Holdings Inc.	5,911	$0.55M	0.0%	-28.5%	0.016%
8/10/2023	Metropolitan Life Insurance Co NY	1,561	$0.16M	0.0%	+4.4%	0.004%
8/10/2023	Great West Life Assurance Co. Can	2,167	$0.22M	0.0%	+69.4%	0.006%
8/10/2023	ProShare Advisors LLC	5,855	$0.60M	0.0%	+6.9%	0.016%
8/10/2023	Profund Advisors LLC	7,007	$0.71M	0.0%	+52.1%	0.019%
8/10/2023	Edgestream Partners L.P.	3,671	$0.37M	0.0%	-70.3%	0.010%
8/10/2023	US Bancorp DE	8,875	$0.91M	0.0%	-8.0%	0.024%
8/10/2023	Charles Schwab Investment Management Inc.	216,012	$22.03M	0.0%	+4.4%	0.575%
8/10/2023	Tekla Capital Management LLC	34,250	$3.49M	0.1%	+91.9%	0.091%
8/10/2023	Citigroup Inc.	16,422	$1.67M	0.0%	-71.7%	0.044%
8/9/2023	TD Asset Management Inc	6,600	$0.67M	0.0%	-25.6%	0.018%
8/9/2023	Swiss National Bank	52,400	$5.34M	0.0%	-10.0%	0.140%
8/9/2023	TimesSquare Capital Management LLC	344,580	$35.13M	0.5%	+10,034.7%	0.918%
8/8/2023	Rhumbline Advisers	48,033	$4.90M	0.0%	+18.9%	0.128%
8/8/2023	Commerce Bank	6,000	$0.61M	0.0%	N/A	0.016%
8/7/2023	Principal Financial Group Inc.	7,051	$0.72M	0.0%	-11.8%	0.019%
8/4/2023	Envestnet Asset Management Inc.	7,176	$0.73M	0.0%	+71.6%	0.019%
8/4/2023	American International Group Inc.	13,757	$1.40M	0.0%	+3.1%	0.037%
8/3/2023	Headlands Technologies LLC	2,602	$0.27M	0.1%	N/A	0.007%
8/3/2023	Barclays PLC	79,034	$8.06M	0.0%	+371.7%	0.210%
8/3/2023	Bank of New York Mellon Corp	132,343	$13.49M	0.0%	+30.2%	0.352%
8/2/2023	Bank of Montreal Can	22,595	$2.31M	0.0%	N/A	0.060%
8/2/2023	State of New Jersey Common Pension Fund D	26,606	$2.71M	0.0%	N/A	0.071%
8/2/2023	Handelsbanken Fonder AB	5,732	$0.58M	0.0%	-30.4%	0.015%
8/2/2023	Sigma Planning Corp	3,775	$0.39M	0.0%	-40.3%	0.010%
8/1/2023	Arizona State Retirement System	6,762	$0.69M	0.0%	-13.5%	0.018%
7/31/2023	Strs Ohio	500	$50K	0.0%	N/A	0.001%
7/28/2023	Braun Stacey Associates Inc.	164,775	$16.80M	0.8%	-47.0%	0.439%
7/28/2023	Moody Aldrich Partners LLC	51,533	$5.25M	1.0%	+4.0%	0.137%
7/27/2023	Victory Capital Management Inc.	211,931	$21.61M	0.0%	+31.1%	0.564%
7/24/2023	Allspring Global Investments Holdings LLC	721	$74K	0.0%	-42.5%	0.002%
7/19/2023	Teacher Retirement System of Texas	6,531	$0.67M	0.0%	-21.4%	0.017%
7/18/2023	Allspring Global Investments Holdings LLC	721	$74K	0.0%	-42.5%	0.002%
7/14/2023	KRS Capital Management LLC	27,941	$2.85M	2.8%	-0.7%	0.074%
7/13/2023	Cambridge Investment Research Advisors Inc.	2,192	$0.22M	0.0%	N/A	0.006%
7/10/2023	SG Americas Securities LLC	4,761	$0.49M	0.0%	-44.4%	0.013%
7/6/2023	MADDEN SECURITIES Corp	21,000	$2.14M	1.1%	-11.4%	0.056%
7/3/2023	LBJ Family Wealth Advisors Ltd.	25,604	$2.61M	1.8%	-14.4%	0.068%
6/14/2023	State Board of Administration of Florida Retirement System	8,707	$0.79M	0.0%	-2.5%	0.023%
5/26/2023	ProShare Advisors LLC	5,479	$0.50M	0.0%	-11.4%	0.015%
5/22/2023	Ameriprise Financial Inc.	5,375	$0.49M	0.0%	-40.4%	0.014%
5/18/2023	New York State Common Retirement Fund	14,529	$1.32M	0.0%	-26.8%	0.040%
5/17/2023	Thrivent Financial for Lutherans	6,819	$0.62M	0.0%	-90.7%	0.019%
5/16/2023	Perceptive Advisors LLC	2,169,276	$197.23M	5.8%	N/A	5.907%
5/16/2023	Sphera Funds Management LTD.	7,689	$0.70M	0.1%	N/A	0.021%
5/16/2023	State Street Corp	632,945	$57.55M	0.0%	-7.6%	1.723%

Data available starting January 2016

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone to treat Friedreich's ataxia; and conduct various form of CKD, such as, type 1 and type 2 diabetic CKD, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental glomerulosclerosis, and others. It is also developing RTA 901 for neurological diseases; and bardoxolone for the treatment of autosomal dominant polycystic kidney disease. In addition, the company has a strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize bardoxolone for renal, cardiovascular, diabetes, and various other related metabolic indications in Japan, China, Hong Kong, Macao, South Korea, Taiwan, Thailand, Singapore, the Philippines, Malaysia, Indonesia, Brunei, Vietnam, Laos, Myanmar, and Cambodia; AbbVie Inc. to jointly research, develop, and commercialize all second- and later-generation Nrf2 activators for all indications other than renal, cardiovascular, and metabolic indications. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas.

Today's Range

Now: $172.36

$172.36

50 Day Range

MA: $162.16

$106.09

$172.36

52 Week Range

Now: $172.36

$21.83

$172.46

Volume

N/A

Average Volume

747,001 shs

Market Capitalization

$6.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

Who are the company insiders with the largest holdings of Reata Pharmaceuticals?: Reata Pharmaceuticals' top insider investors include:
Manmeet Singh Soni (CFO)
Dawn Carter Bir (Insider)
Michael D Wortley (Insider)
Samina Khan (SVP)
Andrea Loewen (SVP)
Bhaskar Anand (CAO)
Shamim Ruff (Director)
Learn More about top insider investors at Reata Pharmaceuticals.
Who are the major institutional investors of Reata Pharmaceuticals?: Reata Pharmaceuticals' top institutional investors include:
BlackRock Inc. — 6.76%
Boxer Capital LLC — 3.81%
State Street Corp — 1.90%
Perceptive Advisors LLC — 1.76%
Holocene Advisors LP — 1.78%
Geode Capital Management LLC — 1.58%
Learn More about top institutional investors of Reata Pharmaceuticals stock.
Which institutional investors are selling Reata Pharmaceuticals stock?: Within the previous quarter, RETA stock was sold by these institutional investors:
Perceptive Advisors LLC
Marshall Wace LLP
JPMorgan Chase & Co.
Braun Stacey Associates Inc.
Citadel Advisors LLC
Simplex Trading LLC
Citigroup Inc.
PDT Partners LLC
In the previous year, company insiders that have sold Reata Pharmaceuticals company stock include:
Manmeet Singh Soni (CFO)
Dawn Carter Bir (Insider)
Michael D Wortley (Insider)
Samina Khan (SVP)
Andrea Loewen (SVP)
Bhaskar Anand (CAO)
Shamim Ruff (Director)
Learn More investors selling Reata Pharmaceuticals stock.
Which institutional investors are buying Reata Pharmaceuticals stock?: During the last quarter, RETA stock was acquired by institutional investors including:
Holocene Advisors LP
TimesSquare Capital Management LLC
BlackRock Inc.
Woodline Partners LP
Point72 Asset Management L.P.
Boxer Capital LLC
Driehaus Capital Management LLC
Suvretta Capital Management LLC